Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 3
2006 6
2007 2
2008 3
2009 3
2017 2
2018 6
2019 14
2020 20
2021 16
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
Ishida K, Kaji K, Sato S, Ogawa H, Takagi H, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Ishida K, et al. Among authors: akahane t. J Nutr Biochem. 2021 Mar;89:108573. doi: 10.1016/j.jnutbio.2020.108573. Epub 2020 Dec 31. J Nutr Biochem. 2021. PMID: 33388347
[Pathophysiology and diagnosis of liver cirrhosis].
Akahane T, Yoshiji H. Akahane T, et al. Nihon Shokakibyo Gakkai Zasshi. 2021;118(1):14-21. doi: 10.11405/nisshoshi.118.14. Nihon Shokakibyo Gakkai Zasshi. 2021. PMID: 33431744 Japanese. No abstract available.
Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.
Tsuji Y, Kawaratani H, Ishida K, Kaya D, Kubo T, Fujinaga Y, Sawada Y, Takaya H, Shimozato N, Kaji K, Namisaki T, Moriya K, Akahane T, Yoshiji H. Tsuji Y, et al. Among authors: akahane t. Dig Dis. 2020;38(4):329-334. doi: 10.1159/000504044. Epub 2019 Oct 25. Dig Dis. 2020. PMID: 31655803 Clinical Trial.
Effect of furosemide on muscle cramps in patients with liver cirrhosis.
Sawada Y, Kawaratani H, Kubo T, Fujinaga Y, Furukawa M, Saikawa S, Sato S, Takaya H, Kaji K, Shimozato N, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H. Sawada Y, et al. Among authors: akahane t. J Gastroenterol Hepatol. 2020 Jan;35(1):76-81. doi: 10.1111/jgh.14820. Epub 2019 Aug 16. J Gastroenterol Hepatol. 2020. PMID: 31385352
Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease.
Tahara K, Akahane T, Namisaki T, Moriya K, Kawaratani H, Kaji K, Takaya H, Sawada Y, Shimozato N, Sato S, Saikawa S, Nakanishi K, Kubo T, Fujinaga Y, Furukawa M, Kitagawa K, Ozutsumi T, Tsuji Y, Kaya D, Ogawa H, Takagi H, Ishida K, Mitoro A, Yoshiji H. Tahara K, et al. Among authors: akahane t. JGH Open. 2019 Oct 1;4(3):400-404. doi: 10.1002/jgh3.12264. eCollection 2020 Jun. JGH Open. 2019. PMID: 32514444 Free PMC article.
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
Furukawa M, Moriya K, Nakayama J, Inoue T, Momoda R, Kawaratani H, Namisaki T, Sato S, Douhara A, Kaji K, Kitade M, Shimozato N, Sawada Y, Saikawa S, Takaya H, Kitagawa K, Akahane T, Mitoro A, Yamao J, Tanaka Y, Yoshiji H. Furukawa M, et al. Among authors: akahane t. Hepatol Res. 2020 Jul;50(7):840-852. doi: 10.1111/hepr.13509. Epub 2020 Jun 10. Hepatol Res. 2020. PMID: 32346970
Role of serum albumin in hepatic encephalopathy.
Akahane T, Yoshiji H. Akahane T, et al. Hepatol Res. 2021 Apr;51(4):353-354. doi: 10.1111/hepr.13632. Hepatol Res. 2021. PMID: 33797845 No abstract available.
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page